Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

OBJECTIVE: To evaluate the efficacy and safety of switching from intravenous (IV) tocilizumab (TCZ) to subcutaneous (SC) TCZ monotherapy in rheumatoid arthritis patients. METHODS: Patients who had completed 24 weeks of TCZ‐SC (162 mg/2 weeks) or TCZ‐IV (8 mg/kg/4 weeks) monotherapy in the double‐bli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Care Res (Hoboken)
Main Authors: Ogata, Atsushi, Atsumi, Tatsuya, Fukuda, Takaaki, Hirabayashi, Yasuhiko, Inaba, Masaaki, Ishiguro, Naoki, Kai, Motokazu, Kawabata, Daisuke, Kida, Daihei, Kohsaka, Hitoshi, Matsumura, Ryutaro, Minota, Seiji, Mukai, Masaya, Sumida, Takayuki, Takasugi, Kiyoshi, Tamaki, Shigenori, Takeuchi, Tsutomu, Ueda, Atsuhisa, Yamamoto, Kazuhiko, Yamanaka, Hisashi, Yoshifuji, Hajime, Nomura, Akira
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5054840/
https://ncbi.nlm.nih.gov/pubmed/25832859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22598
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados